Cross Staff Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Cross Staff Investments's LLY Position: Q2 2026 in Review
Cross Staff Investments held its Eli Lilly (LLY) position steady in Q2 2026 at 2,300 shares worth $2.76M. The position accounts for 1.55% of the portfolio, ranked #15.
Cross Staff Investments first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cross Staff Investments held 2,300 shares of Eli Lilly worth $2.76M as of Q2 2026.
- Cross Staff Investments left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 1.55% of Cross Staff Investments's portfolio in Q2 2026, its #15 holding.
- Cross Staff Investments first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.